Yuhan Corporation (KRX:000100)
South Korea · Delayed Price · Currency is KRW 117,300
-1,100 (-0.93%)
At close: Dec 5, 2025
Yuhan Market Cap
Yuhan has a market cap or net worth of 8.76 trillion as of December 5, 2025. Its market cap has decreased by -11.77% in one year.
Market Cap
8.76T
Enterprise Value
8.77T
Revenue
2.14T
Ranking
n/a
PE Ratio
137.31
Stock Price
117,300.00
Market Cap Chart
Since April 26, 2001, Yuhan's market cap has increased from 231.73B to 8.76T, an increase of 3,678.08%. That is a compound annual growth rate of 15.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 8.76T | -2.11% |
| Dec 30, 2024 | 8.94T | 73.59% |
| Dec 28, 2023 | 5.15T | 25.86% |
| Dec 29, 2022 | 4.09T | -3.94% |
| Dec 30, 2021 | 4.26T | -9.20% |
| Dec 30, 2020 | 4.69T | 58.97% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 77.77T |
| Celltrion | 39.95T |
| ALTEOGEN | 27.76T |
| ABL Bio | 11.08T |
| SK Biopharmaceuticals | 10.67T |
| LigaChem Biosciences | 7.14T |
| Peptron | 6.54T |
| HLB Co., Ltd. | 6.36T |